The present invention provides a TGR5 receptor agonist comprising a fused ring compound represented by the formula
wherein ring A is an optionally substituted aromatic ring; and ring B′ is a 5- to 8-membered ring having one or more substituents or a salt thereof or a prodrug thereof, which is useful for the treatment of various diseases.
The present invention provides a TGR5 receptor agonist comprising a fused ring compound represented by the formula
wherein ring A is an optionally substituted aromatic ring; and ring B' is a 5- to 8-membered ring having one or more substituents or a salt thereof or a prodrug thereof, which is useful for the treatment of various diseases.
本发明提供了一种 TGR5 受体激动剂,其包含由式表示的融合环化合物
其中环 A 是任选取代的芳香环;环 B' 是具有一个或多个取代基的 5 至 8 元环或其盐或其原药,可用于治疗各种疾病。